Inhibitors of unfolded protein response components, such as PERK and IRE1α, are being explored for their potential to sensitize cancer cells to chemotherapy and radiotherapy by exacerbating ER stress, leading to cell death (35, 36). The gene discussed is ERN1; the disease is cancer.